This inventor holds 1 USPTO granted patent. Top assignee: Novagen Holding Corporation. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Innovations of Chungsheng Mao in Recombinant Proteins
Introduction
Chungsheng Mao is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant human interferon-like proteins. His work has implications for the treatment of various viral diseases and cancer.
Latest Patents
Chungsheng Mao holds a patent for recombinant human interferon-like proteins. This application relates to proteins created through gene shuffling technology, which exhibit enhanced anti-viral and anti-proliferative activities compared to naturally occurring human interferon alpha 2b. The invention includes a polynucleotide encoding the protein and recombinant vectors and host cells that comprise the polynucleotide. The polynucleotide is preferably selected from a group of sequences that are at least 93% identical to SEQ ID: No. 1, while the protein is selected from a group of proteins that are at least 85% identical to SEQ ID No: 2. These proteins and their compositions can be utilized for treating conditions responsive to interferon therapy.
Career Highlights
Chungsheng Mao is associated with Novagen Holding Corporation, where he continues to advance his research and innovations. His work has positioned him as a key figure in the biotechnology sector, particularly in the development of therapeutic proteins.
Collaborations
Chungsheng has collaborated with notable colleagues, including Haitao Wang and Jizhi Li. Their combined expertise has contributed to the success of their research endeavors.
Conclusion
Chungsheng Mao's innovative work in recombinant human interferon-like proteins showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of viral diseases and cancer.